CASC
ABBV icon

Coppell Advisory Solutions Corp’s AbbVie ABBV Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$221K Buy
+1,212
New +$209K 0.04% 239
2023
Q1 		$259K Sell
1,639
-141
-8% -$21.6K 0.08% 174
2022
Q4 		$288K Buy
+1,780
New +$273K 0.1% 143

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Coppell Advisory Solutions Corp's ABBV Position: Q1 2024 in Review

Coppell Advisory Solutions Corp opened a new position in AbbVie (ABBV) in Q1 2024: 1,212 shares worth $221K. The stake represents 0.04% of the portfolio and ranks #239 among its holdings. This is a return to the name: Coppell Advisory Solutions Corp previously reported a position in ABBV as recently as Q1 2023.

Coppell Advisory Solutions Corp first reported a position in ABBV in Q4 2022 and has held it in 3 quarters since. The position peaked at $288K in Q4 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Coppell Advisory Solutions Corp held 1,212 shares of AbbVie worth $221K as of Q1 2024.
  • AbbVie was a new Coppell Advisory Solutions Corp position in Q1 2024.
  • AbbVie made up 0.04% of Coppell Advisory Solutions Corp's portfolio in Q1 2024, its #239 holding.
  • Coppell Advisory Solutions Corp first reported a position in AbbVie in Q4 2022 and has held it in 3 quarters since.
  • Coppell Advisory Solutions Corp's AbbVie position peaked at $288K in Q4 2022.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2024, filed 16 May 2024.